Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Potential for lead-time and length-time biases in outcomes in esophageal adenocarcinoma.

Rubenstein JH, Inadomi JM.

Am J Gastroenterol. 2009 Dec;104(12):3106-7; author reply 3107-8. doi: 10.1038/ajg.2009.488. No abstract available.

PMID:
19956133
2.

Claim for screening endoscopy of the esophagus.

Lenglinger J, Riegler M.

Am J Gastroenterol. 2009 Oct;104(10):2632-3; author reply 2633. doi: 10.1038/ajg.2009.420. No abstract available.

PMID:
19806097
3.

Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends.

Cooper GS, Kou TD, Chak A.

Am J Gastroenterol. 2009 Jun;104(6):1356-62. doi: 10.1038/ajg.2009.159. Epub 2009 May 12.

PMID:
19491849
4.

Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States).

Farrow DC, Vaughan TL.

Cancer Causes Control. 1996 May;7(3):322-7.

PMID:
8734825
5.

Re: The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

Forman D.

J Natl Cancer Inst. 2005 Jul 6;97(13):1013-4; author reply 1014. No abstract available.

PMID:
15998956
6.
7.

Management of esophageal cancer.

Schuchert MJ, Luketich JD, Landreneau RJ.

Curr Probl Surg. 2010 Nov;47(11):845-946. doi: 10.1067/j.cpsurg.2010.07.002. Review. No abstract available.

PMID:
20937424
8.

Esophageal adenocarcinoma incidence: are we reaching the peak?

Pohl H, Sirovich B, Welch HG.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1468-70. doi: 10.1158/1055-9965.EPI-10-0012. Epub 2010 May 25. Erratum in: Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2416.

9.

The rising incidence of esophageal adenocarcinoma.

Sharma P, Sampliner RE.

Adv Intern Med. 2001;46:137-53. Review. No abstract available.

PMID:
11147251
10.

Colorectal cancer in patients with esophageal adenocarcinoma.

Vaughan TL, Kiemeney LA, McKnight B.

Cancer Epidemiol Biomarkers Prev. 1995 Mar;4(2):93-7.

11.

The changing epidemiology of esophageal adenocarcinoma.

Wei JT, Shaheen N.

Semin Gastrointest Dis. 2003 Jul;14(3):112-27. Review.

PMID:
14653411
12.

Where are you and how do we find you? The dilemma of identifying Barrett's epithelium before adenocarcinoma of the esophagus.

Wong RK, Altekruse SF.

Am J Gastroenterol. 2009 Jun;104(6):1363-5. doi: 10.1038/ajg.2009.167.

PMID:
19436281
13.

Esophageal cancer: an update.

Shahbaz Sarwar CM, Luketich JD, Landreneau RJ, Abbas G.

Int J Surg. 2010;8(6):417-22. doi: 10.1016/j.ijsu.2010.06.011. Epub 2010 Jun 30. Review.

14.

Age effects and temporal trends in adenocarcinoma of the esophagus and gastric cardia (United States).

Jeon J, Luebeck EG, Moolgavkar SH.

Cancer Causes Control. 2006 Sep;17(7):971-81.

PMID:
16841264
15.

Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment.

DeMeester SR.

Ann Surg Oncol. 2006 Jan;13(1):12-30. Epub 2006 Jan 1. Review.

PMID:
16378161
16.

The epidemic of esophageal adenocarcinoma.

el-Serag HB.

Gastroenterol Clin North Am. 2002 Jun;31(2):421-40, viii. Review.

PMID:
12134611
17.

Presentation and prognosis of esophageal adenocarcinoma in patients below age 50.

Hashemi N, Loren D, DiMarino AJ, Cohen S.

Dig Dis Sci. 2009 Aug;54(8):1708-12. doi: 10.1007/s10620-008-0565-7. Epub 2008 Nov 22.

PMID:
19030991
18.

Diagnostic and therapeutic endoscopy.

Kuipers EJ, Haringsma J.

J Surg Oncol. 2005 Dec 1;92(3):203-9. Review.

PMID:
16299782
19.

Esophageal adenocarcinoma and Barrett's esophagus.

Sayana H, Wani S, Sharma P.

Minerva Gastroenterol Dietol. 2007 Jun;53(2):157-69. Review.

PMID:
17557044
20.

Carcinoma of the esophagus: an overview.

Harvey JC, Beattie EJ.

Compr Ther. 1994;20(1):55-60. Review. No abstract available.

PMID:
8137621

Supplemental Content

Support Center